| Berberine | Activates AMPK, the same metabolic pathway targeted by first-line oral diabetes medication. Meta-analyses report HbA1c reductions of roughly 0.7 to 1.4 percentage points, and small head-to-head trials found it comparable to first-line medication.4 Read that with care: the trials are mostly small and of low methodological quality, no long-term cardiovascular outcomes trial exists, and berberine does not appear in NICE guideline NG28. | 500mg 3x/day with meals | With each meal to reduce postprandial spikes | Monitor glucose closely if combined with hypoglycemic medications, dose adjustments likely needed. GI tolerance improves after the first 2 weeks. Berberine inhibits CYP3A4 and P-glycoprotein, so it can raise blood levels of many prescription medicines, and it lowers blood sugar on its own. Check with your prescriber before starting it, particularly alongside glucose-lowering medication, an anticoagulant, an immunosuppressant, or any drug with a narrow safe range. Not for use in pregnancy or breastfeeding. |
| Chromium Picolinate | A cofactor in insulin receptor signalling, and deficiency impairs glucose tolerance. The evidence genuinely conflicts. Meta-analyses report HbA1c reductions of roughly 0.6 to 0.7 percentage points and fasting glucose reductions between 19 and 29 mg/dL, but reviewers note the larger effects cluster in the poorer-quality studies, and at least one meta-analysis found no meaningful fasting glucose benefit.5 The NIH's National Center for Complementary and Integrative Health reaches the same verdict, that chromium may offer some benefit for glycaemic control but the research conflicts.14 | 400โ1,000mcg/day | With the largest carbohydrate-containing meal | Picolinate form has best absorption. Not recommended in excess (>1,000mcg/day) as high chromium has genotoxic potential. Standard doses are safe. |
| Magnesium Glycinate | Magnesium is a cofactor in glucose metabolism, and people with type 2 diabetes are frequently depleted, partly because high blood sugar increases urinary magnesium loss. A dose-response meta-analysis found roughly a 0.73 percentage point HbA1c reduction at 500 mg/day, while a separate pooled analysis of 23 trials found the effect on HbA1c minimal.6 NCCIH's assessment is that clinical trials have not shown a clear benefit.14 Fasting glucose improves more consistently than HbA1c does. | 400โ600mg elemental magnesium/day The upper intake level for supplemental magnesium is 350 mg/day; above that the usual effect is loose stools rather than harm, but it is worth knowing. | With dinner or before bed | Glycinate form is best absorbed and causes no laxative effect. RBC magnesium level (not serum) is the accurate test for total body status. |
| Alpha-Lipoic Acid (ALA) | An antioxidant used for diabetic peripheral neuropathy, and approved for that indication in Germany. The strongest evidence is for intravenous ALA at 600 mg/day over three weeks. Oral evidence is weaker and less consistent, though a recent network meta-analysis did find oral ALA effective for neuropathic pain.7 Most oral supplement guidance is extrapolated from the intravenous trials, which is a real limitation. | 600โ1,200mg/day (R-ALA preferred) | 30 minutes before meals, fasted for best absorption | R-ALA is 4x more bioavailable than S-ALA (racemic). Stabilized R-ALA (Na-RALA) prevents degradation. Thiamine (B1) supplementation enhances ALA efficacy for neuropathy. |
| Ceylon Cinnamon | The evidence conflicts, and it is worth knowing that. A 2012 Cochrane review found cinnamon no better than placebo for fasting glucose, insulin or HbA1c. A later meta-analysis found a fasting glucose reduction of about 24.6 mg/dL, but with a wide confidence interval and high heterogeneity; roughly 8 of 14 trials show a benefit and 6 show none.8 NCCIH summarises the trial data as conflicting.14 Choosing Ceylon over Cassia matters for a separate reason: Cassia contains far more coumarin, which is hepatotoxic at sustained high intake. | 1โ3g/day (as capsules or ground in food) | With meals | MUST be Ceylon cinnamon only, Cassia cinnamon contains high levels of coumarin, a hepatotoxin at these doses. Verify species on label. |
| Apple Cider Vinegar | Acetic acid slows gastric emptying and blunts the rise in blood sugar after a meal. A meta-analysis of vinegar trials found a significant reduction in post-meal glucose. A 2025 GRADE-assessed review in type 2 diabetes reported a fasting glucose reduction of about 21.9 mg/dL and an HbA1c reduction of about 0.5 percentage points.9 Trials are small and results vary between them. | 1โ2 tbsp diluted in 8oz water | Before the two largest meals of the day | Raw, unfiltered with "mother." Must be diluted to protect tooth enamel and esophagus. Contraindicated with potassium-depleting diuretics and NSAIDs at high doses. |
| Gymnema Sylvestre | Gymnemic acids blunt sweet taste and appear to reduce intestinal glucose absorption. The human evidence is weak. In one systematic review of ten controlled studies, only two were randomised and two double-blind, most reported only before-and-after change rather than a comparison against a control group, and heterogeneity was very high.10 Treat any specific number for Gymnema with caution. | 400โ800mg/day (standardized to 25% gymnemic acids) | Before meals containing carbohydrates | Well-tolerated. May reduce effectiveness of hypoglycemic medications, monitor glucose. Also sold as "GS4" standardized extract. |
| Inositol (Myo-inositol) | A cellular messenger involved in insulin signal transduction. Its strongest evidence sits outside type 2 diabetes. Meta-analyses of randomised trials found myo-inositol in pregnancy substantially reduced the incidence of gestational diabetes, by roughly 44% across 12 trials in 4,765 women, though a 2023 Cochrane review judged the evidence not yet sufficient to be confident.13 Evidence in polycystic ovary syndrome is also stronger than in type 2 diabetes, so its relevance on this page is indirect rather than direct. | 2โ4g/day myo-inositol (or 40:1 ratio myo:D-chiro) | With meals, split doses | Most evidence for PCOS-associated insulin resistance. Combine with D-chiro-inositol at 40:1 ratio for synergistic effect on ovarian insulin sensitivity. |
| Vitamin D3 | Vitamin D receptors on pancreatic beta cells are involved in insulin secretion, and deficiency is common in type 2 diabetes. Observational data link higher vitamin D levels to modestly lower HbA1c, but supplementation trials have not shown that correcting deficiency prevents or reverses type 2 diabetes. Dosing: the tolerable upper intake level for adults is 4,000 IU/day, and the Endocrine Society suggests 1,500 to 2,000 IU/day. Intakes below 10,000 IU/day are not usually associated with toxicity in the published literature, but sustained intake above the upper limit should only be undertaken with blood testing and clinical supervision, particularly with any kidney impairment.11 | Do not self-prescribe. Test 25(OH)D first and follow your clinician's guidance. | With the largest fat-containing meal | Test 25(OH)D before supplementing. Take with K2 (MK-7, 100โ200mcg) to direct calcium to bones and away from arteries. Retest at the interval your clinician advises. |
